These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37663252)

  • 21. Nebulized Versus IV Amikacin as Adjunctive Antibiotic for Hospital and Ventilator-Acquired Pneumonia Postcardiac Surgeries: A Randomized Controlled Trial.
    Hassan NA; Awdallah FF; Abbassi MM; Sabry NA
    Crit Care Med; 2018 Jan; 46(1):45-52. PubMed ID: 28857848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant
    Mantzarlis K; Manoulakas E; Parisi K; Sdroulia E; Zapaniotis N; Tsolaki V; Zakynthinos E; Makris D
    Antibiotics (Basel); 2024 Jan; 13(2):. PubMed ID: 38391527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives.
    Zhu Y; Monsel A; Roberts JA; Pontikis K; Mimoz O; Rello J; Qu J; Rouby JJ;
    Microorganisms; 2021 May; 9(6):. PubMed ID: 34072189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study on intravenous combined with aerosol inhalation of polymyxin B for the treatment of pneumonia caused by multidrug-resistant Gram-negative bacteria].
    Zhou L; Li C; Weng Q; Wu J; Luo H; Xue Z; Xiao Y; Chen C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):416-420. PubMed ID: 34053483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study.
    Feng JY; Huang JR; Lee CC; Tseng YH; Pan SW; Chen YM; Yang KY
    Ann Intensive Care; 2023 Jan; 13(1):1. PubMed ID: 36609725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Susceptibility of MDR-
    Hasan MJ; Rabbani R; Anam AM; Santini A; Huq SMR
    J Crit Care Med (Targu Mures); 2021 Jan; 7(1):28-36. PubMed ID: 34722901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous combined with aerosolised polymyxins vs intravenous polymyxins monotherapy for ventilator-associated pneumonia: A systematic review and meta-analysis.
    Tong R; Zou X; Shi X; Zhang X; Li X; Liu S; Duan X; Han B; Wang H; Zhang R; Sun L; Kong Y; Zhang F; Ma M; Ding X; Sun T
    Int J Antimicrob Agents; 2024 Dec; 64(6):107357. PubMed ID: 39389385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymyxin Monotherapy vs. Combination Therapy for the Treatment of Multidrug-resistant Infections: A Systematic Review and Meta-analysis.
    Samal S; Samir SB; Patra SK; Rath A; Dash A; Nayak B; Mohanty D
    Indian J Crit Care Med; 2021 Feb; 25(2):199-206. PubMed ID: 33707900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
    Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
    Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
    Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials.
    Monsel A; Torres A; Zhu Y; Pugin J; Rello J; Rouby JJ;
    Curr Opin Infect Dis; 2021 Apr; 34(2):156-168. PubMed ID: 33605620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children.
    Jia X; Yin Z; Zhang W; Guo C; Du S; Zhang X
    Front Pharmacol; 2022; 13():902054. PubMed ID: 35712713
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli.
    Hao M; Yang Y; Guo Y; Wu S; Hu F; Qin X
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis.
    Lu D; Mao W
    Heliyon; 2023 May; 9(5):e15774. PubMed ID: 37159708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins.
    Huang Y; Liao M; Hu X; Hu H; Gong H
    J Antimicrob Chemother; 2024 Dec; 79(12):3210-3229. PubMed ID: 39351975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial.
    Cisneros JM; Rosso-Fernández CM; Roca-Oporto C; De Pascale G; Jiménez-Jorge S; Fernández-Hinojosa E; Matthaiou DK; Ramírez P; Díaz-Miguel RO; Estella A; Antonelli M; Dimopoulos G; Garnacho-Montero J;
    Crit Care; 2019 Nov; 23(1):383. PubMed ID: 31779711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profile of infective microorganisms causing ventilator-associated pneumonia: A clinical study from resource limited intensive care unit.
    Thakuria B; Singh P; Agrawal S; Asthana V
    J Anaesthesiol Clin Pharmacol; 2013 Jul; 29(3):361-6. PubMed ID: 24106362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety Factors Related to Plasma Concentration-Optimized Polymyxin B Therapy in Treating Carbapenem-Resistant Gram-Negative Bacterial Infections in China.
    Li L; Huang X; Liu J; Li C; Lin Z; Ren R; Zhang Y; Ding H; Chen J; Mao Y
    Infect Drug Resist; 2024; 17():3057-3071. PubMed ID: 39050834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical analysis of colistin sulfate in the treatment of pneumonia caused by carbapenem-resistant Gram-negative bacteria.
    Xu HC; Cui Y; Wang XY; Wu HB; Li W; Wang D; Lin N; Lin L; Zhang YH
    World J Clin Cases; 2024 May; 12(13):2173-2181. PubMed ID: 38808336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.